GlassScriptPhysician profile
Austin Mccadden
NPI 1710568464
$3,349.35
in general payments reported to CMS, 2019-2025
9 companies · $246 in 2025
The $246 reported for 2025 was more than what a typical General Practice provider received nationally (typical 2025 total: $105).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $2,621 · 2023: $350 · 2024: $132 · 2025: $246.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $728.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $727.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Elevate Surgical Co | $2,475.97 | 2022-2025 | |
| Linvatec Corporation | $316.12 | 2023-2025 | Biobrace 23mm, Linvatec Shoulder Arthroscopy |
| Stryker Corporation | $294.94 | 2023-2024 | Iconix, Nanotack Flex, Salvation |
| Heron Therapeutics, INC. | $122.51 | 2022 | |
| Medtronic, INC. | $74.82 | 2022 | |
| Orthofix Medical, INC. | $21.78 | 2024 | Accelstim |
| Solventum Corporation | $21.03 | 2025 | V.A.C. Dermatac, Prevena, V.A.C. Veraflo |
| Paragon 28, INC. | $14.99 | 2023 | Gorilla |
| Skeletal Dynamics INC | $7.19 | 2023 | Ijs, Geminus, Align |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Austin Mccadden listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.